Actiste’s Unified IoT Diabetes Care Device Awarded CE Mark – Diabetes
Actiste, the world’s first unified diabetes care device with eSIM technology for monitoring and treating insulin-dependent diabetes, has received not only one, but two, EC certificates (CE marks) from TÜV Rheinland (Notified Body). The collection of and feedback on valid real life health data will facilitate optimized and personalized diabetes management and contribute to the improvement of everyday metabolic control and enable behavioral change. Actiste is delivered as part of a subscription service; Actiste Diabetes Management as a Service.